SEC Form 4 · accession 0000899243-18-011956
UNIVERSAL BIOSENSORS INC · UBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick L Legleiter
Officer — Chief Executive Officer
Period of report
May 4, 2018
Accepted (ET)
May 8, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279695
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 4, 2018 | P | 158,687 | $0.2585 | A | 158,687 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4 | $0.50 | holding | — | — | — | — | Oct 23, 2022 | Common Stock | 1,600,000 | 1,600,000 | D |
| Stock Option (Right to Buy)F3,F4 | $0.60 | holding | — | — | — | — | Oct 23, 2022 | Common Stock | 2,700,000 | 2,700,000 | D |
| Stock Option (Right to Buy)F3,F4 | $0.80 | holding | — | — | — | — | Oct 23, 2022 | Common Stock | 3,300,000 | 3,300,000 | D |
Explanation of responses
- F1Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
- F2The price reported in Column 4 is a weighted average price and is stated in Australian dollars. These shares were purchased in multiple transactions at prices ranging from AU$0.24 to AU$0.27. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3The price reported is stated in Australian dollars.
- F4The options were granted on October 24, 2017. The options will vest and only become exercisable on the date that is three years from the date of grant of the options, subject to continued employment at the time of vesting. If the Company terminates the employment without cause prior to the vesting date, a proportion of the options will vest, being the same as the proportion of the three year vesting period that the employee served with the Company.